Amarantus Bioscience Holdings Inc (AMBS)

[gobears1985]

Are you responding to my post? My post was in response to the idiots that are claiming the use of the word qualitative in today's PR is a sign that ducks are not in a row. My point was that you can't have quantitative revenue guidance for a product that hasn't generated quantifiable revenue yet. It's impossible by definition. Qualitative is the only option at this point is the use of that word should not be criticized. You either misread my post or didn't read what I was responding to. I'm confident that lympro revenue will be just fine once it gets going.